BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu D, Wang H, Yan W, Chen T, Wang M, Han M, Wu Z, Wang X, Ai G, Xi D, Shen G, Luo X, Ning Q. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2. Immunol Res 2016;64:518-30. [PMID: 26482053 DOI: 10.1007/s12026-015-8727-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Van Tong H, Van Ba N, Hoan NX, Binh MT, Quyen DT, Son HA, Van Luong H, Quyet D, Meyer CG, Song LH, Toan NL, Velavan TP. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases. BMC Infect Dis 2018;18:553. [PMID: 30419833 DOI: 10.1186/s12879-018-3473-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Delgado-Chaves FM, Gómez-Vela F, Divina F, García-Torres M, Rodriguez-Baena DS. Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks. Genes (Basel) 2020;11:E831. [PMID: 32708319 DOI: 10.3390/genes11070831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hefler J, Marfil-Garza BA, Pawlick RL, Freed DH, Karvellas CJ, Bigam DL, Shapiro AMJ. Preclinical models of acute liver failure: a comprehensive review. PeerJ 2021;9:e12579. [PMID: 34966588 DOI: 10.7717/peerj.12579] [Reference Citation Analysis]
4 Yu H, Liu Y, Wang H, Wan X, Huang J, Yan W, Xi D, Luo X, Shen G, Ning Q. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. Front Immunol 2018;9:2935. [PMID: 30619295 DOI: 10.3389/fimmu.2018.02935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]